Perspective Therapeutics, Inc. (CATX)
NYSE: CATX · CIK 0000728387 · United States
Every official Perspective Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CATX filings
Perspective Therapeutics, Inc. documents
- Perspective Therapeutics, Inc. 10-K 2026CATX 10-K 2026: annual report for fiscal 2026
- Perspective Therapeutics, Inc. 10-K 2025CATX 10-K 2025: annual report for fiscal 2025
- Perspective Therapeutics, Inc. 10-K 2024CATX 10-K 2024: annual report for fiscal 2024
- Perspective Therapeutics, Inc. 10-K 2023CATX 10-K 2023: annual report for fiscal 2023
- Perspective Therapeutics, Inc. 10-K 2022CATX 10-K 2022: annual report for fiscal 2022
- Perspective Therapeutics, Inc. 10-Q 2026CATX 10-Q 2026: quarterly report for fiscal 2026
- Perspective Therapeutics, Inc. 10-Q 2025CATX 10-Q 2025: quarterly report for fiscal 2025
- Perspective Therapeutics, Inc. 10-Q 2024CATX 10-Q 2024: quarterly report for fiscal 2024
- Perspective Therapeutics, Inc. 10-Q 2023CATX 10-Q 2023: quarterly report for fiscal 2023
- Perspective Therapeutics, Inc. 10-Q 2022CATX 10-Q 2022: quarterly report for fiscal 2022
- Perspective Therapeutics, Inc. 8-K 2026CATX 8-K 2026: current report for fiscal 2026
- Perspective Therapeutics, Inc. 8-K 2025CATX 8-K 2025: current report for fiscal 2025
- Perspective Therapeutics, Inc. 8-K 2024CATX 8-K 2024: current report for fiscal 2024
- Perspective Therapeutics, Inc. 8-K 2023CATX 8-K 2023: current report for fiscal 2023
- Perspective Therapeutics, Inc. 8-K 2022CATX 8-K 2022: current report for fiscal 2022
- Perspective Therapeutics, Inc. DEF 14A 2026CATX DEF 14A 2026: proxy statement for fiscal 2026
- Perspective Therapeutics, Inc. DEF 14A 2025CATX DEF 14A 2025: proxy statement for fiscal 2025
- Perspective Therapeutics, Inc. DEF 14A 2024CATX DEF 14A 2024: proxy statement for fiscal 2024
- Perspective Therapeutics, Inc. DEF 14A 2023CATX DEF 14A 2023: proxy statement for fiscal 2023
- Perspective Therapeutics, Inc. DEF 14A 2022CATX DEF 14A 2022: proxy statement for fiscal 2022
- Perspective Therapeutics, Inc. Form 4 2026CATX Form 4 2026: insider trading filing for fiscal 2026
- Perspective Therapeutics, Inc. Form 4 2025CATX Form 4 2025: insider trading filing for fiscal 2025
- Perspective Therapeutics, Inc. Form 4 2024CATX Form 4 2024: insider trading filing for fiscal 2024
- Perspective Therapeutics, Inc. Form 4 2023CATX Form 4 2023: insider trading filing for fiscal 2023
- Perspective Therapeutics, Inc. Form 4 2022CATX Form 4 2022: insider trading filing for fiscal 2022
- Perspective Therapeutics, Inc. S-1 2026CATX S-1 2026: registration statement for fiscal 2026
- Perspective Therapeutics, Inc. S-1 2025CATX S-1 2025: registration statement for fiscal 2025
- Perspective Therapeutics, Inc. S-1 2024CATX S-1 2024: registration statement for fiscal 2024
- Perspective Therapeutics, Inc. S-1 2023CATX S-1 2023: registration statement for fiscal 2023
- Perspective Therapeutics, Inc. S-1 2022CATX S-1 2022: registration statement for fiscal 2022
- Perspective Therapeutics, Inc. 13F 2026CATX 13F 2026: institutional holdings for fiscal 2026
- Perspective Therapeutics, Inc. 13F 2025CATX 13F 2025: institutional holdings for fiscal 2025
- Perspective Therapeutics, Inc. 13F 2024CATX 13F 2024: institutional holdings for fiscal 2024
- Perspective Therapeutics, Inc. 13F 2023CATX 13F 2023: institutional holdings for fiscal 2023
- Perspective Therapeutics, Inc. 13F 2022CATX 13F 2022: institutional holdings for fiscal 2022
More companies